Huang JQ et al. |
Do patients with non-ulcer dyspepsia respond differently to Helicobacter pylori eradication treatments from those with peptic ulcer disease? A systematic review. |
2005 |
World J. Gastroenterol. |
pmid:15884111
|
Gumurdulu Y et al. |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey. |
2004 |
World J. Gastroenterol. |
pmid:14991935
|
Guo CY et al. |
Clinical evaluation of four one-week triple therapy regimens in eradicating Helicobacter pylori infection. |
2004 |
World J. Gastroenterol. |
pmid:14991953
|
Mirbagheri SA et al. |
Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: a comparative three-armed randomized clinical trial. |
2006 |
World J. Gastroenterol. |
pmid:16937475
|
Attaran B et al. |
Effect of biofilm formation by clinical isolates of on the efflux-mediated resistance to commonly used antibiotics. |
2017 |
World J. Gastroenterol. |
pmid:28275296
|
Miehlke S et al. |
Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study). |
2001 |
World J. Gastroenterol. |
pmid:11819768
|
Trifan A et al. |
Pseudomembranous colitis associated with a triple therapy for Helicobacter pylori eradication. |
2013 |
World J. Gastroenterol. |
pmid:24259981
|
Babic Z et al. |
Increased activity of Pgp multidrug transporter in patients with Helicobacter pylori infection. |
2005 |
World J. Gastroenterol. |
pmid:15884110
|
Wang B et al. |
Standard triple therapy for Helicobacter pylori infection in China: a meta-analysis. |
2014 |
World J. Gastroenterol. |
pmid:25356059
|
Ji F et al. |
Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial. |
2006 |
World J. Gastroenterol. |
pmid:16586550
|
Sereni G et al. |
Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection. |
2012 |
World J. Gastroenterol. |
pmid:22969227
|
Aydemir S et al. |
Helicobacter pylori infection in hemodialysis patients: susceptibility to amoxicillin and clarithromycin. |
2005 |
World J. Gastroenterol. |
pmid:15682477
|
Wang CH et al. |
Effects of daily telephone-based re-education before taking medicine on Helicobacter pylori eradication: A prospective single-center study from China. |
2015 |
World J. Gastroenterol. |
pmid:26494972
|
Zhao LJ et al. |
Helicobacter pylori isolates from ethnic minority patients in Guangxi: resistance rates, mechanisms, and genotype. |
2014 |
World J. Gastroenterol. |
pmid:24782630
|
Gao XZ et al. |
Standard triple, bismuth pectin quadruple and sequential therapies for Helicobacter pylori eradication. |
2010 |
World J. Gastroenterol. |
pmid:20818821
|
Pan W et al. |
Effects of clopidogrel and clarithromycin on the disposition of sibutramine and its active metabolites M1 and M2 in relation to CYP2B6*6 polymorphism. |
2013 |
Xenobiotica |
pmid:22830954
|
Kanayama N et al. |
Drug-drug interactions in the metabolism of imidafenacin: role of the human cytochrome P450 enzymes and UDP-glucuronic acid transferases, and potential of imidafenacin to inhibit human cytochrome P450 enzymes. |
2007 |
Xenobiotica |
pmid:17484517
|
Burt HJ et al. |
IC50-based approaches as an alternative method for assessment of time-dependent inhibition of CYP3A4. |
2010 |
Xenobiotica |
pmid:20230210
|
Kubo JI et al. |
Pharmacokinetic evaluation of high pulmonary disposition of clarithromycin after systemic administration. |
2002 |
Xenobiotica |
pmid:12419017
|
Yamamoto T et al. |
Prediction of oral clearance from in vitro metabolic data using recombinant CYPs: comparison among well-stirred, parallel-tube, distributed and dispersion models. |
2005 |
Xenobiotica |
pmid:16192112
|